title: Letter to the Editor: Possible Decrease in GIP Levels May Explain Increased Plasma Dipeptidyl Peptidase-4 Activity-Associated Osteoporosis.
authors.affiliation: Department of Endocrinology and Metabolism, Diskapi Teaching and Research Hospital, 06330 Ankara, Turkey.
authors.forename: Muhammed
authors.initials: M
authors.lastname: Kizilgul
authors.affiliation: Department of Endocrinology and Metabolism, Diskapi Teaching and Research Hospital, 06330 Ankara, Turkey.
authors.forename: Erkam
authors.initials: E
authors.lastname: Sencar
authors.affiliation: Department of Endocrinology and Metabolism, Diskapi Teaching and Research Hospital, 06330 Ankara, Turkey.
authors.forename: Bekir
authors.initials: B
authors.lastname: Ucan
authors.affiliation: Department of Endocrinology and Metabolism, Diskapi Teaching and Research Hospital, 06330 Ankara, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Ozbek
authors.affiliation: Department of Endocrinology and Metabolism, Diskapi Teaching and Research Hospital, 06330 Ankara, Turkey.
authors.forename: Erman
authors.initials: E
authors.lastname: Cakal
mesh_terms: D015519:Bone Density / Q000502:physiology*; D018819:Dipeptidyl Peptidase 4 / Q000097:blood*; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D010024:Osteoporosis / Q000097:blood*; D017698:Postmenopause / Q000097:blood*
chemical_list: D018819:Dipeptidyl Peptidase 4